It has been reported, however, that GLI1 signaling is activated in a subset of NSCLC through the mechanism of overexpression of GLI1 transcription factor with no deregulation of PTCH or SMOH [18]. The gene discussed is GLI1; the disease is non-small cell lung carcinoma.